Thieler Law Corp Announces Investigation of Intra-Cellular Therapies

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Intra-Cellular Therapies Inc (NASDAQ: ITCI) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Intra-Cellular Therapies Inc (NASDAQ: ITCI) concerning whether a series of statements by Intra-Cellular Therapies Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On December 18, 2018, the Company revealed in a press release that "an independent data monitoring committee (DMC) has completed a pre-specified interim analysis of the Company's ongoing clinical trial with low-dose lumateperone (9 mg ITI-007) for the treatment of agitation in patients with probable Alzheimer's disease (Study 201)."  According to Intra-Cellular Therapies: "the DMC concluded that Study 201 is not likely to meet its primary endpoint upon completion and therefore recommended the study should be stopped for futility.  As a result of this recommendation, the Company has determined to discontinue Study 201." 

On this news, NASDAQ: ITCI fell sharply during intraday trading on December 18, 2018.

Based in New York, New York, Intra-Cellular Therapies Inc engages in developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases.

If you purchased shares of Intra-Cellular Therapies Inc (NASDAQ: ITCI) on or before December 18, 2018, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185